Hong Kong Arbele is a clinical stage biotech centred on an innovative T-Cell Engager approach to gastrointestinal cancers. Chairman and founder John Luk explains the prevalence of these cancers in China, the company’s challenging clinical trials journey, and the pursuit of breakthrough and fast-track designations in the US and an IND in…
See our Cookie Privacy Policy Here
